ImmunoGen Inc (NASDAQ:IMGN)

7.54
Delayed Data
As of Mar 03
 -0.35 / -4.44%
Today’s Change
5.34
Today|||52-Week Range
17.49
+23.61%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close7.89
Today’s open7.89
Day’s range7.43 - 7.90
Volume1,091,935
Average volume (3 months)1,845,994
Market cap$679.4M
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+21.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book8.95

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.33-1.14%
FPRXFive Prime Therapeut...-1.33-5.10%
HPTXHyperion Therapeutic...-0.39-1.29%
BCRXBioCryst Pharmaceuti...-0.22-2.14%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateApril 24, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account